RecruitingNCT06853236

Functional Incremental Stepping in Place Test (F-IST) Validation

A Cardiorespiratory Fitness Test for Acute Illness: Validity, Reliability, and Clinical Utility of Functional Incremental Stepping-in-Place Test


Sponsor

Kirby Mayer

Enrollment

60 participants

Start Date

Jul 2, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this multi-site prospective study is to assess validity of a new step test called Functional-Incremental Stepping-in-place- Test (F-IST) compared to gold-standard cardiopulmonary exercise testing (CPET) and to physical function and health perception, respectively. The investigators will also assess test-retest reliability of the F-IST. The investigators hypothesize that the F-IST will have high validity and test-retest reliability to be used in field testing environments such as the ICU.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Currently able to walk with or without a walking aid, such as a cane or walker or rollator

Exclusion Criteria23

  • Pregnancy
  • specifically related to cardiopulmonary testing
  • A recent significant change in resting ECG
  • Unstable angina
  • Uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise
  • Symptomatic severe aortic stenosis
  • Uncontrolled symptomatic heart failure
  • Acute pulmonary embolus or pulmonary infarction
  • Acute myocarditis or pericarditis
  • Suspected or known dissecting aneurysm
  • Acute systemic infection accompanied by fever, body aches, or swollen lymph glands
  • Left Main Coronary Stenosis
  • Moderate stenotic valvular heart disease
  • Electrolyte abnormalities
  • Severe arterial hypertension (\>200 systolic, \>110 diastolic) at rest
  • Tachydysrhythmia or bradydysrhythmia
  • Hypertrophic cardiomyopathy and other forms of outflow tract obstruction
  • Neuromuscular, musculoskeletal, or rheumatic disorders that are exacerbated by exercise
  • High degree AV block
  • Ventricular aneurysm
  • Uncontrolled metabolic disease (diabetes, thyrotoxicosis, or myxedema)
  • Chronic infectious disease (hepatitis, AIDS, mono)
  • Mental or physical impairment leading to inability to exercise adequately

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Florida Atlantic University

Boca Raton, Florida, United States

Duke University

Durham, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06853236


Related Trials